Bullseye Asset Management LLC Bluebird Bio, Inc. Transaction History

Bullseye Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$11.24 - $21.0 $1.77 Million - $3.32 Million	-157,872 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$18.04 - $22.09 $1.62 Million - $1.99 Million	90,000 Added 132.6%	157,872 $5.05 Million
Q1 2021 May 13, 2021	BUY	$16.59 - $33.89 $581,097 - $1.19 Million	35,027 Added 106.64%	67,872 $2.05 Million
Q4 2020 Feb 12, 2021	BUY	$27.5 - $37.92 $129,580 - $178,679	4,712 Added 16.75%	32,845 $1.42 Million
Q3 2020 Nov 12, 2020	SELL	$34.44 - $43.75 $688 - $875	-20 Reduced 0.07%	28,133 $1.52 Million
Q2 2020 Aug 11, 2020	BUY	$27.12 - $45.97 $763,509 - $1.29 Million	28,153 New	28,153 $1.72 Million

160

80M

525K

634K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $37.8M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Bullseye Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Bullseye Asset Management LLC with notifications on news.